Adenomyoma of ampulla: a rare cause of obstructive jaundice

Kumari, Neeraj; Vij, Mukul

doi:10.1093/jscr/2011.8.6

Cited by 9 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 To date, 58 cases of adenomyoma of the major papilla have been described in the English literature. 3,6,[11][12][13][14][15][16] However, adenomyoma of the minor papilla is extremely rare, with only one case reported. 7 Although a previous review in 1999 showed a higher prevalence in women, with a female/male ratio of 3:1, 17 we did not find any significant difference after reviewing all cases published to date.…”

Section: Discussionmentioning

confidence: 99%

Combination of Adenomyoma and Adenomyomatous Hyperplasia of the Ampullary System: A First Case Report

et al. 2018

View full text Add to dashboard Cite

Adenomyoma and adenomyomatous hyperplasia are benign tumor-like lesions that rarely involve the major or minor duodenal papilla. We report the case of a 73-year-old patient who underwent a cephalic duodenopancreatectomy due to clinical and radiological evidence of underlying malignant neoplasm. The histopathology results revealed the unusual association of a major duodenal papilla adenomyoma and an adenomyomatous hyperplasia of the minor papilla. Because of their resemblance to pancreatic malignancy, the diagnosis of these lesions is particularly challenging. In most cases, it is established postoperatively, after histopathological examination of the surgical specimen.

show abstract

Section: Discussionmentioning

confidence: 99%

Combination of Adenomyoma and Adenomyomatous Hyperplasia of the Ampullary System: A First Case Report

et al. 2018

View full text Add to dashboard Cite

show abstract

“…However, since the introduction of calcineurin based immunosuppressive therapy (especially tacrolimus), the improved surgical outcomes and graft survival has resulted in an increase in the number of PTA's conducted, which as of December 2011 accounted for 7.7% of all US pancreas transplantations reported to the IPTR [3]. PTA is usually reserved for patients with a GFR of >80 mls/min/1.73 m 2 , without proteinuria (or with mild stable proteinuria) [2].…”

Section: Types Of Pancreas Transplantationmentioning

confidence: 99%

“…In the past 48 years, Pancreatic transplantation has evolved from being entirely experimental to becoming a well established therapeutic modality [3], with more than 37,000 surgeries worldwide, being reported to the international pancreas transplantation registry (IPTR) in the year 2010 [3]. Most of the pancreas graft recipients usually have type 1 diabetes; however, about 7.7% have type 2 diabetes [2].…”

Section: Introductionmentioning

confidence: 99%

Pancreas and Beta Islet Cell Transplantation - Evidence Base and Outcomes

Said¹

2016

J Diabetes Metab

View full text Add to dashboard Cite

From a humble experimental debut in 1966, pancreatic transplantation has undergone significant advances undoubtedly becoming the gold standard endocrine replacement therapy for diabetes in our current time. With more than 37,000 surgeries registered with the international pancreas transplantation registry (IPTR) in the year 2010, it is fair to assume that transplantation of the pancreas has become an established therapeutic modality. of the three major types of transplantation surgeries; simultaneous pancreas and kidney transplantation (SPK) is the most commonly performed surgery, followed by pancreas after kidney transplantation (PAK), and finally pancreas transplantation alone (PTA) being the least commonly performed. For patients with contraindications to both exogenous insulin and whole pancreas transplantation; less invasive beta islet cell transplantion presents a viable therapeutic modality.This review article aims to explore the evidential base that supports whole pancreatic and beta islet cell transplant as therapeutic modalities in diabetes mellitus, as well as describing the indications, contraindications, advantages, disadvantages and outcomes associated with these forms of treatment.

show abstract

“…However, small adenomyomas (2–5 mm) are common and reported in 60% of the population in autopsies, with no relevant associated clinical history ( 2 ). Adenomyoma in the AOV is usually detected incidentally without symptoms ( 2 3 ), but it may manifest symptoms such as abdominal pain and jaundice when the lesion causes biliary obstruction ( 5 6 ).…”

Section: Introductionmentioning

confidence: 99%

Differentiation of Adenomyoma from Localized Adenocarcinoma of the Ampulla of Vater Using Multidetector CT

Park

Lee

Kim

et al. 2021

J Korean Soc Radiol

View full text Add to dashboard Cite

Purpose To determine the multidetector CT (MDCT) findings that differentiate adenomyoma of the ampulla of Vater (AOV) from localized adenocarcinoma of the AOV. Materials and Methods Sixteen and 30 patients with adenomyoma and localized adenocarcinoma of the AOV, respectively, were evaluated using MDCT. We analyzed the size and attenuation value and presence of uniform enhancement of the lesions, diameters of the extrahepatic bile duct (EHD) and main pancreatic duct, presence of regional lymph node enlargement, and laboratory findings. We determined the independent findings for differentiating adenomyoma from localized adenocarcinoma of the AOV using multivariate analysis. Results The size of the lesion and diameter of the EHD were significantly smaller for adenomyoma than those for localized adenocarcinoma of the AOV (all p < 0.001). In multivariate analyses, a lesion size of ≤ 1.3 cm, an EHD diameter of ≤ 1.3 cm, and an alanine transaminase level of ≤ 31 IU/L significantly differentiated adenomyoma from localized adenocarcinoma of the AOV. When all of these three findings were met, the specificity for adenomyoma of the AOV was 93.3%. Conclusion MDCT imaging may facilitate the differential diagnosis of adenomyoma and localized adenocarcinoma of the AOV based on the size of the lesion and diameter of the EHD.

show abstract

Adenomyoma of ampulla: a rare cause of obstructive jaundice

Cited by 9 publications

References 5 publications

Combination of Adenomyoma and Adenomyomatous Hyperplasia of the Ampullary System: A First Case Report

Combination of Adenomyoma and Adenomyomatous Hyperplasia of the Ampullary System: A First Case Report

Pancreas and Beta Islet Cell Transplantation - Evidence Base and Outcomes

Differentiation of Adenomyoma from Localized Adenocarcinoma of the Ampulla of Vater Using Multidetector CT

Contact Info

Product

Resources

About